Beaumont Hospital at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Beaumont Hospital takes part in 5 sessions at ESMO 2026 in Madrid. Its program centres on lung cancer care, especially managing patients on antibody-drug conjugates and the side effects of newer immunotherapies. It also covers an immune gene signature linked to lung inflammation from immune checkpoint inhibitors in non-small cell lung cancer, plus treatment of extensive-stage small cell lung cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
Beaumont Hospital Dublin, Ireland | |
Public teaching hospital in Dublin, Ireland, affiliated with RCSI University of Medicine and Health Sciences. | Abstract Sun Oct 25 09:14–09:19 4247RO - Immunogenomic signature associated with ICI-related pneumonitis in non- small-cell lung cancer (NSCLC) patients Biomarkers & precision oncology Satellite Sun Oct 25 10:15–11:45 AstraZeneca - On the frontlines: Optimizing ADC patient care in lung cancer Lung & thoracic cancersNursing & supportive care Satellite Sun Oct 25 10:15–10:20 Opening remarks Lung & thoracic cancersNursing & supportive care Satellite Sun Oct 25 10:20–10:30 ADCs unpacked - Overview of ADCs in lung cancer Lung & thoracic cancersNursing & supportive care Satellite Sun Oct 25 11:05–11:35 Applying multidisciplinary approaches to real-world scenarios - Case study presentation followed by moderated group discussion and Q&A Lung & thoracic cancersNursing & supportive care Satellite Sun Oct 25 11:35–11:45 ADC PRIME spotlight -Showcase of the ADC PRIME toolkit and its uses - Closing of the session Lung & thoracic cancersNursing & supportive care Talk Mon Oct 26 11:15–11:35 Management of toxicities from next generation immunotherapies Lung & thoracic cancers Satellite Mon Oct 26 13:05–13:25 Current Management Strategies for ES-SCLC Lung & thoracic cancers Abstract Mon Oct 26 17:06–17:18 Invited Discussant LBA10 Gynaecological cancersSarcoma, CNS, head & neck and rare cancers |
Instantly find 20 buyers from Beaumont Hospital
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction